EMA encourages NAMs to replace animal testing, aligning with 3Rs principles, and has published a concept paper on regulatory acceptance. EFPIA supports phasing out animal testing, emphasizing ...
A Cambridge hub leverages dense co-location with universities, hospitals, and ~470 life science companies to compress translational cycles and expand collaboration in data-driven discovery and ...
Campbell Bunce, chief scientific officer at Abzena, provides an update on the momentum in antibody-oligonucleotide conjugates development and the operational pressures shaping CDMO/CRO strategy for ...
KPV, and TB-500 to the compounding list, with MOTs-C also recommended, signaling potential near-term changes in legal supply channels. Online “research-use” peptide distribution has expanded without ...
According to Schniepp, inspectors are not auditing the electronic submission mechanism itself because the eCTD system is ...
Kent Malmros is senior director of training at Veeva Systems. He has spent the majority of his career delivering technology-enabled training solutions to life-sciences companies and has held ...
Leading manufacturers now deploy validated agentic AI that detects OOS events, retrieves batch records, correlates prior deviations, and drafts RCA packages, yielding ≥50% faster investigations.
Megha Sinha, founder and CEO of Kolter AI and Kamet Consulting Group, spoke with PharmTech at the beginning of 2026 about her ...
AI is reshaping discovery, manufacturing, and supply chain routing. Manufacturers are investing in capacity and resilience. In news this week, Novo Nordisk has sued Eli Lilly, alleging its Zepbound ...
Brent Wilhelm, Cencora, comments on cold chain pharma growth, a $1B supply chain investment, and a 2027 hub built to curb drug shortages. Access part 1 of this interview on why pharma supply chains ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results